A sirtuin enzyme (Sirt2) has been identified as a key player in regulating hepatic glucokinase or hepatic glucose uptake (HGU) through modifying glucokinase regulatory protein (GKRP), suggesting that this mechanism offers a potential therapeutic target for type 2 diabetes.
